The affected mandate requires that all newborns receive erythromycin ointment applied to their eyes after birth, which helps ...

The FDA did not agree with a supplemental Biologics License Application for the addition of extended dosing intervals of up ...

CsA Ophthalmic Gel is an innovative cyclosporine gel being developed by Zhaoke in China for the treatment of moderate to ...

Authors defined metabolic syndrome as “the set of factors that increase the risk of cardiovascular disease and diabetes, such ...

A survey collected demographic data, ocular and medical history, and responses assessing knowledge of glaucoma and cataracts ...

Leos is supported by emerging data from a randomized controlled clinical trial, further validating its safety and efficacy.

The research team noted that racial subgroups are underrepresented in clinical trials, a factor that should be addressed in ...

The sBLA seeks approval for Eylea HD for both the treatment of macular edema following retinal vein occlusion and broadening ...

Mah previews a packed 2025 Annual Meeting, from the debut of SightLine to Dr. Glaucomflecken’s return to the main stage, and ...

ARVO meeting will be held in Salt Lake City, Utah and feature presentation on clinical trials from around the globe.

In honor of Ophthalmology Times’ 50th anniversary, we asked a panel of leading ophthalmologists and optometrists across ...

New ISO standards categorize SVIOLs into multifocal, EDOF, and FVR IOLs, requiring rigorous clinical testing for ...